Letter to the Editor: Re: Aspartate aminotransferase-to-platelet ratio index (APRi) as biomarker for liver damage in biliary atresia (BA): a meta-analysis

Abstract

I appreciate the authors’ thoughtful response to my letter and their effort to clarify the methodological scope of their meta-analysis on APRi in biliary atresia [1]. I fully recognize the clinical relevance of the topic and the challenges of synthesizing heterogeneous data. My comments are intended to improve methodological transparency and interpretive consistency. I thank the authors for their clarifications, which help delineate the boundaries of their analytical approach.

Keywords

Hashtags

This article is published on an external journal. Click below to read the full text.